COVID-19与急性肾损伤的独立关联:多中心队列研究
这项多中心队列研究纳入2020年3月至8月期间Yale New Haven健康系统6家医院住院并接受SARS-CoV-2检测的22122例患者,其中2600例阳性。通过时间更新Cox模型调整人口学、合并症、生命体征、用药和实验室结果后,COVID-19仍与AKI高风险独立相关(aHR 1.40,95%CI 1.29-1.53)。
要点
- COVID-19患者AKI发生率30.6%,高于阴性患者的18.2%,绝对风险差12.5%。
- COVID-19患者需透析的AKI比例8.5%,高于阴性患者的3.6%。
- 调整传统危险因素后,COVID-19仍与AKI独立相关(aHR 1.40)。
核心结论
- COVID-19与AKI高风险独立相关,且不能完全由已知危险因素解释。
研究设计与样本
- 多中心、观察性队列研究,纳入6家医院22122例住院患者,其中2600例SARS-CoV-2阳性、19522例阴性。
主要发现
- COVID-19患者AKI发生率30.6%,阴性患者18.2%,绝对风险差12.5%(95%CI 10.6%-14.3%)。
- COVID-19患者需透析的AKI比例8.5%,阴性患者3.6%。
- COVID-19患者AKI恢复率58%,低于阴性患者的69.8%。
- COVID-19患者炎症标志物(C反应蛋白、铁蛋白)水平更高,血管升压药和利尿剂使用更多。
- 单变量分析中COVID-19与AKI风险比1.84(95%CI 1.73-1.95),完全调整后aHR 1.40(95%CI 1.29-1.53)。
关键数值与推荐
- AKI定义采用KDIGO标准。
- 调整因素包括人口学特征、合并症、生命体征、用药和实验室结果。
临床怎么用
- 临床应警惕COVID-19患者发生AKI及需透析的风险,并关注AKI恢复延迟。
局限性
- 可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Although coronavirus disease 2019 (COVID-19) has been associated with acute kidney injury (AKI), it is unclear whether this association is independent of traditional risk factors such as hypotension, nephrotoxin exposure, and inflammation. We tested the independent association of COVID-19 with AKI. STUDY DESIGN: Multicenter, observational, cohort study. SETTING & PARTICIPANTS: Patients admitted to 1 of 6 hospitals within the Yale New Haven Health System between March 10, 2020, and August 31, 2020, with results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing via polymerase chain reaction of a nasopharyngeal sample. EXPOSURE: Positive test for SARS-CoV-2. OUTCOME: AKI by KDIGO (Kidney Disease: Improving Global Outcomes) criteria. ANALYTICAL APPROACH: Evaluated the association of COVID-19 with AKI after controlling for time-invariant factors at admission (eg, demographic characteristics, comorbidities) and time-varying factors updated continuously during hospitalization (eg, vital signs, medications, laboratory results, respiratory failure) using time-updated Cox proportional hazard models. RESULTS: Of the 22,122 patients hospitalized, 2,600 tested positive and 19,522 tested negative for SARS-CoV-2. Compared with patients who tested negative, patients with COVID-19 had more AKI (30.6% vs 18.2%; absolute risk difference, 12.5% [95% CI, 10.6%-14.3%]) and dialysis-requiring AKI (8.5% vs 3.6%) and lower rates of recovery from AKI (58% vs 69.8%). Compared with patients without COVID-19, patients with COVID-19 had higher inflammatory marker levels (C-reactive protein, ferritin) and greater use of vasopressors and diuretic agents. Compared with patients without COVID-19, patients with COVID-19 had a higher rate of AKI in univariable analysis (hazard ratio, 1.84 [95% CI, 1.73-1.95]). In a fully adjusted model controlling for demographic variables, comorbidities, vital signs, medications, and laboratory results, COVID-19 remained associated with a high rate of AKI (adjusted hazard ratio, 1.40 [95% CI, 1.29-1.53]). LIMITATIONS: Possibility of residual confounding. CONCLUSIONS: COVID-19 is associated with high rates of AKI not fully explained by adjustment for known risk factors. This suggests the presence of mechanisms of AKI not accounted for in this analysis, which may include a direct effect of COVID-19 on the kidney or other unmeasured mediators. Future studies should evaluate the possible unique pathways by which COVID-19 may cause AKI.
引用
- Moledina DG, Simonov M, Yamamoto Y, et al. The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study. Am J Kidney Dis. 2021. PMID: 33422598. doi:10.1053/j.ajkd.2020.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。